Dr. Bharti Mangla

Assistant Professor

School of Pharmaceutical Sciences (SPS)

bhartimangla@dpsru.edu.in

Google Scholar Scopus Profile

ORCID: 0000-0001-5125-2150?lang=en

Educational Qualifications

M. Pharm; Ph.D.

Area of Specialization / Research

Formulation Development, Targeted nano drug delivery system, Cancer therapy, Synergistic carrier system, Quality by design (QbD)

Notable Publications

1.
Journal/Vol./PP
2.
14 – 2023 |
2023
3.
Molecules; 28(5):2343
4.
Arabian Journal of Chemistry
5.
Pharmaceutics
6.
Journal of Pharmaceutical Innovation
7.
Recent Patents on Anti-cancer Drug Discovery
8.
Nanotechnology Reviews
9.
Shamama Javed, Bharti Mangla, Waquar Ahsan
10.
Phytotherapy Research (Accepted)
11.
Alhazmi, Hassan A., Waquar Ahsan, Bharti Mangla , Shamama Javed, Mohd Zaheen Hassan, Mufarreh Asmari, Mohammed Al Bratty, and Asim Najmi
12.
Nanotechnology Reviews;11(1):96- 116
13.
Reena, Bharti Mangla , Yubraj Neupane, Kushagra Khanna, Harvinder Popli.
14.
Nanotechnology; 32(50):505102
15.
Bharti Mangla, Shamama Javed, Muhammad Hadi Sultan, Pankaj Kumar, Kanchan Kohli, Asim Najmi, Hassan A. Alhazmi, Mohammed Al Bratty, Waquar Ahsan
16.
Phytotherapy Research, 35 (10), 5440-5458
17.
Bharti Mangla, Shamama Javed, Muhammad Hadi Sultan, Waquar Ahsan, Geeta Aggarwal, and Kanchan Kohli.
18.
Frontiers in Pharmacology, 4022.
19.
Bharti Mangla , Kanchan Kohli, Saifu Rabiu
20.
Current Traditional Medicine. 7, 125- 137.
21.
Bharti Mangla , Sarwar Beg, Ozair Alam, Waquar Ahsan, Anzarul Haque, Kuldeep Singh Patel, Waleed Hassan Almalki, Majed Alrobaian, Kanchan Kohli
22.
Arabian Journal of Chemistry, 11, 7909-7920
23.
Development and validation of a high throughput bioanalytical UPLCMS/ MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study
24.
Journal of Chromatography B, 1152, 122260- 122289
25.
Lipid-nanopotentiated combinatorial delivery of tamoxifen and sulforaphane: ex vivo , in vivo and toxicity studies
26.
Nanomedicine, 15(26), 2563-2583
27.
Reassessment of therapeutic applications of carbon nanotubes: A majestic and futuristic drug carrier
28.
Critical Reviews in Therapeutic Drug Carrier Systems, 37(4), 331–373
29.
Vicissitudes of liquid crystals for solubility enhancement of poorly soluble drugs
30.
Journal of Molecular Liquids, 321, 114924
31.
PEGylated Nanoliposomes Potentiated Oral Combination Therapy for Effective Cancer Treatment
32.
Current Drug Delivery, 17(9), 728–735
33.
Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment
34.
Nanotechnology, 31(47), 475101
35.
Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19
36.
Frontiers in Public Health. 8, 384
37.
PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer
38.
Journal of Molecular Liquids. 303, 112649
39.
therapy: in vitro and in vivo assessment
40.
Bharti Mangla , Kuldeep Singh Patel, Pankaj Kumar, Kanchan Kohli
41.
Validation of forced degradation and stability indicating studies of Tamoxifen in nanoformulation using spectroscopic technique
42.
Material Todays Proceeding, 26(2), 3265-3270
43.
Bharti Mangla , Yub Raj Neupane, Archu Singh, Kanchan Kohli
44.
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approach
45.
Medical Hypotheses, 132, 109379-109384
46.
Archu Singh, Yub Raj Neupane, Bharti Mangla , Kanchan Kohli
47.
Nanostructured Lipid Carriers for oral bioavailability enhancement of Exemestane: Formulation design, in vitro, ex vivo and in vivo studies
48.
Journal of Pharmaceutical Sciences, 108, 3382-3395
49.
Surbhi Ranjan, Bharti Mangla , Archu Singh & Kanchan Kohli
50.
Method Development and Validation of Exemestane and Stress Degradation Studies using UV Spectrophotometry
51.
Latin American Journal of Pharmacy, 38 (2): 414-423
52.
Bharti Mangla , Kanchan Kohli
53.
Combination of Natural Agent with Synthetic Drug for the Breast Cancer Therapy
54.
International Journal of Drug Development and Research, 10, 22- 26
55.
Bharti Mangla , Kanchan Kohli
56.
Pharmaceutical and therapeutic potential of miraculin and miracle berry
57.
Tropical Journal of Natural Product Research, 2 (1), 12-17
58.
Bharti Mangla , Kuldeep singh Patel, Pankaj Kumar, Giriraj T Kulkarni
59.
Ligand mediated carbon nanotubes-based delivery of an anticancer agent
60.
Latin American Journal of Pharmacy, 36; 208

Awards & Achievements